SecBot SecBot
SECBOTREPLAY Home › Report › SNDX

SNDX · Syndax Pharmaceuticals filed a DEFA14A (additional definitive proxy…

Syndax Pharmaceuticals Inc · DEFA14A filed Apr 30, 2026 at 17:22 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 30, 2026 at 17:22 ET

Syndax Pharmaceuticals filed a DEFA14A (additional definitive proxy soliciting materials) on April 30, 2026. The filing is a definitive additional proxy statement, but the actual document content is unavailable, only the SEC filing header and metadata are provided. The filing type suggests ongoing proxy solicitation activity, but without document text, no specific proposals, activist demands, or financial figures can be extracted.

  • Filed DEFA14A on April 30, 2026
  • Filed by Syndax Pharmaceuticals Inc (ticker: SNDX)
  • Document content was not available for analysis
  • Market cap: $1.8B with 95% analyst bullish consensus

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access